Royalty Pharma(RPRX) - 2025 FY - Earnings Call Transcript

Royalty Pharma (NasdaqGS:RPRX) FY 2025 Conference December 02, 2025 03:15 PM ET Company ParticipantsTerrance Coyne - CFOMarshall Urist - Head of Research and InvestmentsNone - ModeratorNoneBiopharma analyst and today we have Royalty Pharma, so we have Terry Coyne, CFO; Marshall Urist, EVP, Head of R&I, research and investments. Right. Once that R&D and people got really.Marshall UristKind of like hooked up, yeah.Yeah. Yeah.Okay.Dana like almost fired me. Yeah. So, I guess on the back of a very successful ye ...